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Abstract.  To determine the effects of transforming 
growth factor-~ (TGF-[3) on the different cell types 
that exist in bone, cell populations (I-IV), progres- 
sively enriched in osteoblastic cells relative to fibro- 
blastic cells, were prepared from fetal rat calvaria 
using timed collagenase digestions.  TGF-I~ did not in- 
duce anchorage-independent  growth of these cells, nor 
was anchorage-dependent growth stimulated in most 
populations studied, despite a two- to threefold in- 
crease in the synthesis of cellular proteins.  In all 
populations the synthesis of secreted proteins increased 
2-3.5-fold.  In particular,  collagen,  fibronectin, and 
plasminogen activator inhibitor synthesis was stimu- 
lated.  However, different degrees of stimulation of in- 
dividual proteins were observed both within and be- 
tween cell populations.  A  marked preferential 
stimulation of plasminogen activator inhibitor was ob- 
served in each population,  together with a  slight 
preferential  stimulation of collagen; the effect on colla- 
gen expression being directed primarily at type I col- 
lagen.  In contrast,  the synthesis of SPARC  (secreted 
protein acidic rich in cysteine/osteonectin was stimu- 
lated approximately two-fold by TGF-13, but only in 
fibroblastic populations.  Collectively, these results 
demonstrate that TGF-~  stimulates matrix production 
by bone cells and,  through differential effects on in- 
dividual matrix components,  may also influence the 
nature of the matrix formed by different bone cell 
populations.  In the presence of TGF-13, osteoblastic 
cells lost their polygonal morphology and alkaline 
phosphatase activity was decreased, reflecting a  sup- 
pression of osteoblastic features. The differential 
effects of TGF-13 on bone cell populations are likely to 
be important in bone remodeling and fracture repair. 
T 
RANSFORMING growth factor-I] (TGF-l]) ~ is a 25-kD 
dimeric polypeptide that  can affect the growth,  dif- 
ferentiation,  and activity of a variety of different cell 
types (17, 32).  Although  present in most normal  and trans- 
formed  cells  studied,  TGF-l]  is  stored  in  relatively  high 
amounts in platelets,  suggesting a role for this growth factor 
in wound healing  (1). TGF-[3 is also concentrated  in bone, 
where it was originally identified as a cartilage-inducing  fac- 
tor (29) that exists in two forms, CIF-A and CIF-B. Recently, 
two major forms and a minor form of porcine TGF-l] have 
been isolated (5). The major forms are distinct homodimers, 
whereas the minor form is a heterodimer.  Amino acid se- 
quence data  indicate  that the major forms of TGF-l] cor- 
respond to CIF-A and CIF-B (30). 
TGF-l] promotes a wound healing response in vivo that is 
characterized  by increased cellular proliferation  and protein 
synthesis (25, 31). Studies of connective tissue cells in vitro 
have demonstrated  that  TGF-[3 stimulates  the synthesis  of 
matrix  protein including  collagen and fibronectin  (7, 9, 25, 
1. Abbreviations used in this paper: SPARC, secreted protein acidic rich in 
cysteine; TGF-13, transforming growth factor-13. 
39). In studies of bone, TGF-l] has been shown to stimulate 
bone resorption (33), to be mitogenic for cells in fetal rat cal- 
variae,  and,  on transitory  exposure,  to stimulate  collagen 
and protein synthesis by calvarial cells in organ culture (3). 
More recently, the mitogenic effect of TGF-[3 on osteoblast- 
enriched populations of fetal calvarial cells in monolayer cul- 
tures was shown to be independent  of the stimulation  of col- 
lagen synthesis (4).  Several factors known to regulate bone 
metabolism,  such as parathormone and  1,25(OH)2 vitamin 
D3, can stimulate  TGF-l] activity in cultures of rodent cal- 
variae  (22),  and  in  particular,  1,25(OH)2 vitamin  D3 has 
been shown to stimulate TGF-l]-like  activity in a rat osteo- 
blastic  cell line  (21). The concentration  of TGF-l] in bone 
matrix  and its stimulation  in osteoblastic cells indicate that 
TGF-l] may function in the modulation of resorption and for- 
mation that occurs during bone remodeling  and in the pro- 
cess of bone repair. 
In this study we have analyzed the effects of TGF-l] on ma- 
trix protein synthesis by bone cells derived from fetal rat cal- 
varia. Because bone cells are highly heterogeneous (2), we 
have isolated distinct populations  of bone cells that range in 
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The effects of low levels (0.1 and 1.0 ng/ml) of TGF-13 on the 
osteoblastic cells could then be diff renfiated from responses 
of fibroblastic cells. These studies have concentrated on the 
effect of TGF-13 on the synthesis of the secreted proteins, col- 
lagen and fibronectin,  that are involved in the formation of 
connective tissue matrix.  In addition,  we have studied the 
effect of TGF-13 on osteonectin, a prominent calcium-binding 
glycoprotein  synthesized  by  osteoblastic  and  fibroblastic 
cells  (20,  37,  40) that is relatively  abundant in bone and 
rapidly  remodeling  connective  tissues  (35).  Osteonectin 
appears to be highly homologous to SPARC protein (6a, 8), 
a 40-1:3) glycoprotein originally recognized as the major pro- 
tein induced by retinoids in the differentiation of parietal en- 
doderm cells, and to a 43-kD "culture shock" protein synthe- 
sized by bovine endothelial  cells (15, 16, 26,  27), and the 
basement membrane protein BM-40 (14). The expression of 
SPARC/osteonectin  may, therefore, be related to the wound 
healing response and could also be an indicator of cellular 
differentiation. 
Materials and Methods 
The isolation of fetal rat catvarial cell poFdations, the conditions of ceil cul- 
ture (23, 38), and methods used for protein synthesis were carried out essen- 
tially as described in detail elsewhere (30) and are reported here in an ab- 
breviated form. 
Isolation and Culture of  Bone Cell Populations 
Frontal and parietal bones from 21-d-old rat fetuses were cleaned of peri- 
ostea and loose soft connective tissue and washed in ice-cold PBS contain- 
ing antibiotics as described previously (23), Approximately 30 calvariae 
were minced with scissors into small pieces and digested at 37~  with 5 ml 
of a sterile bacterial collagenase solution. After I0 min, the released cells 
were collected and immediately mixed with an equal volume of FBS. The 
procedure was repeated to release cells at 20, 30, 50, and 70 min after the 
initial digestion. Since few cells were obtained at 70 rain they were com- 
bined with the 50-min digestion to produce four populations (I-IV). The 
individual cell populations were filtered through a 200-mesh sieve to remove 
debris and the cells collected by centrifugation at 400 g for 5 min. The cells 
were then resuspended in r  minimal essential medium (a-MEM) containing 
15%  (vol/vol) FBS and antibiotics and plated in T-75 tissue culture flasks 
and grown to confluence. 
Fetal rat calvarial ceU populations prepared as described above exhibited 
a range of morphologies from spindle shaped (fibroblastic) to polygonal (os- 
teoblastic).  Further, the later-eluting populations were enriched with os- 
teoblastic ceils, as indicated by greater cAMP response to parathormone, 
higher alkaline phosphatase levels, and synthesis of lower amounts of type 
III collagen. 
After trypsinization, 1-3 ￿  104 cells from each population were seeded 
into triplicate 35-ram culture dishes and grown to confluence. Cells were 
synchronized by incubation for 24 h in I% (vol/~ol) FBS before being in- 
cubated with TGF-t3 (purified from human platelets as described previously 
[1] and generously supplied by Dr. M. 13. Sporn, National Cancer Institute, 
National Institutes of Health, Bethesda, MD) at 0.I and 1.0 ng/ml or with 
vehicle (I  mg/ml BSA in 4  mM HCI)  alone in ct-MEM containing 1% 
(vol/vol) FBS for 24 h in a humidified incubator at 37~  The choice of a 
24-h incubation time was based on a time course study of TGF-[3 on human 
gingival fibroblasts in which the 24-h time point appears representative of 
long-term effects of TGF-13 on protein synthesis (Wrana, J. L., and J. Sodek, 
manuscript in preparation). 
Cell Growth  Analysis 
Anchorage-dependent growth of bone cells was determined after a single 
24-h exposure to TGF-t~ Calls were removed from the tissue culture dishes 
by incubating at 37~  for 10-15 rain with le0 mi 0.15%  (wt/vol) trypsin in 
citrate-saline  buffer and quantitatively transferred  into  19  ml  of lsoton 
(Coulter Electronics, Inc., Hialeah, FL), and the cell number determined 
on a Coulter Counter (model ZF; Coulter Electronics Inc., Hialeah, FL). 
For anchorage independent growth, colony formation in 0.3%  (wt/vot) 
soft agar was measured using the method of DeLarco and Todaro (6) except 
that a  7  mt basal layer of 0.5%  (wt/vot) agar was used with fully sup- 
plemented ct-MEM as the incubation medium. Mixed populations with cell 
densities of l0  s cells/2 ml 0.3%  (wt/vol) agar in triplicate 60-mm petri 
dishes were used for these studies. 
Analysis of Protein Synthesis 
To analyze the synthesis of cell-associated and secreted proteins, confluent 
cells were  pulse-chased  with  [~S]methionine.  After  a  24-h  incubation 
period with or without TGF-13, triplicate 35-ram dishes were washed in 
methionine-free DME over a  15-min period, and each dish incubated at 
37DC in 1.0 ml of the same medium containing 50 ~tg/ml sodium ascorbate 
and 75 ~tCi [35S]methionine (NEG-O09H; sp act > 400 Ci/mmol; New En- 
gland Nuclear, Boston, MA) for 30 min. After the pulse period the ceils 
were washed twice in ct-MEM containing 0.2% (vol/vol) FBS and incubated 
for a further 4 h at 37~C in 2.0 ml of the same medium. The chase media 
were dialyzed in the presence of proteolytic enzyme inhibitors against three 
changes of distilled water. Cell layers were washed three times with ice-cold 
TBS, pH Z4, then scraped into L0 ml of 50 mM Tris/HC1, pH 7.4, contain- 
ing protease inhibitors, and sonicated. Aliquots of the radiolabeled media 
and cell layer were analyzed by scintillation counting and by fluorography 
after PAGE in the presence of SDS on 5-20% cross-linked gradient gels and 
7.5% cross-linked linear gels as described previously (30). 
Analysis of  Collagen Synthesis 
Equal aliquots of the culture media containing I-5  x  I(P dpm were freeze 
dried and reconstituted in 1.13 ml assay buffer (50 mM "IYis/HCI,  5  mM 
CaCt2, pH 7.5). Samples ofO.5 ml were incubated with and without 25 Ixg 
highly purified bacterial coltagenase in the presence of 2.5 n~M N-ethyl- 
maleimide at 37~  for 2 h. The undigested noncollagenous protein was then 
precipitated in the presence of 50 lxg BSA by ice-cold TCA, 7% (wt/vol) 
final concentration.  The supernataut was quantitatively removed and ex- 
tracted with diethyl ether to remove the TCA and then the radioactivity de- 
termined by scintillation counting. The radioactivity incorporated into col- 
lagenous proteins was determined by subtracting the radioactivity in the 
control from the collagenase-digested sample. The radioactivity in the non- 
collagenous protein was determined after extracting any residual collagen 
(<3% total radioactivity) from the pellet with hot ~  and dissolving the 
remaining pellet in 100 ~tl of 70% (vol/vol) formic acid before scintillation 
counting. 
Analysis of Collagen ~pes 
Atiquots of culture media containing 0.5-2  ￿  104 dpm were freeze-dried 
and redissolved in 100 Itl 0.5 M acetic acid adjusted to pH 2.2 with HCI. 
50 ttg pepsin in 100 ~tl of the same solution was added and the digestion 
carried out for 4 h at 15~  The solution was immediately fwaze-dried be- 
fore  analyzing by  SDS-PAGE  on 7.5%  cross-linked  gels using delayed 
reduction. The collagen a chains corresponding to collagen types I, III, and 
V were visualized by fluorograpby and quantitated from several exposures 
(12)  using a  laser densitometer  (LKB  Ultroscan  XL;  Fisher Scientific, 
Toronto, Ontario, Canada), interfaced with a Macintosh Plus. Integration 
of densitometrie scans was performed using the Curves program developed 
by Dr.  P.  N.  Lewis (Department of Biochemistry, University of Toronto, 
Ontario, Canada). 
Analysis of  Fibronectin Synthesis 
Fibronectin was selectively and quantitatively bound to gelatin-Sepharose 
(Pharmacia, Inc., Piscataway, NJ) pre-equilibrated in TBS and contained in 
individual minicolumns. Atiquots of media containing 1--4 ￿  104 dpm ra- 
dioactivity were brought to 0.5% (vol/vol) Triton X-100, using a 20% (vol/ 
vol) Triton stock solution in water, and allowed to percolate slowly (1 h at 
22~  through 100 I11 gelatin-Sepharose resin held in a 1-ml plastic micro- 
pipette tip with a small plug of glass wool. The affinity column was washed 
with 1.0 ml of 0.5 M NaCI in TBS followed by a  l-ml wash in TBS alone. 
The fibronectin was then eluted with 100 Ixl of double strength SDS-PAGE 
sample buffer and aliquots taken for scintillation counting and SDS-PAGE 
analysis. Cell-associated fibronectin could not be purified sufficiently by 
this procedure for scintillation analysis and was, therefore, quantitated by 
densitometric analysis of fluorographs of the mdiolabeled protein separated 
on SDS-PAGE using 5-20% cross-linked gradient gels. In each case the ex- 
posure of fluorographs were adjusted to permit densitometric analysis in the 
linear range. 
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Equal aliquots (0.5  ml) of radiolabeled culture medium were diluted with 
an  equal  volume of immunoprecipitation buffer (0.3%  [vol/vol]  NP-40, 
0.3%  [vol/vol]  sodium deoxycholate, 0.15%  [wt/vol] BSA in TBS, 0.02% 
[wt/vol]  sodium azide) at a twofold concentration, and incubated with 5 p.1 
preimmune serum in a 1.5 ml plastic Microfuge tube (Bio-Rad Laboratories, 
Richmond, CA) for 2 h at 4~  Immune complexes formed were removed 
from solution by adding 100 p.I protein A-Sepharose (Pharmacia, Inc.) and 
incubation for 1 h at 4~  After centrifuging for 5 rain at 10,000 g, the super- 
natant was incubated overnight at 4~  with 3  I.tl rabbit anti-SPARC/os- 
teonectin antiserum raised against porcine bone osteonectin (6a).  A second 
100 p.1 aliquot of protein A-Sepharose was then added and incubated for 1 
h. The specific immunoprecipitate obtained was pelleted by centrifugation 
for 5 min and washed four times with immunoprecipitation buffer.  The ra- 
diolabeled protein in the fnal pellet was dissolved in 100 p.l electrophoresis 
sample buffer containing 75 I~g dithiothreitol by heating to 95~  for 10 min. 
Aliquots were taken for scintillation counting and analysis by SDS-PAGE 
on 12% cross-linked gels. Because of  a slight contamination of  high relative 
molecular mass material in the specific immunoprecipitates, densitometric 
analysis of fluorographs was used for quantitation. 
Alkaline Phosphatase Activity 
To  assay  for alkaline phosphatase activity,  cells  in 35-mm dishes were 
washed three times with ice-cold TBS  and scraped into 0.5  ml 50  mM 
Tris/HCI buffer,  pH 7.4, and the dishes rinsed with 0.5 ml Tris buffer.  The 
cell layer suspension was sonicated on ice with two 10-s pulses on a sonifier 
at setting No. 5 (Branson Sonic Power Co., Danbury, CT). After centrifuga- 
tion for 5 min at 10,000 g, 25 lal of the supernatant was mixed with 100 lal 
of substrate (7.5  mM p-nitrophenyl-phosphate [Sigma Chemical Co..  St. 
Louis,  MO]  in 2.6 mM MgCI2  in 0.33  M  2-amino-2-methyl-l-propanol, 
pH 10.3 [buffer No. 221, Sigma Chemical Co.]) in individual wells of a 96- 
well tissue culture plate.  The plate was then incubated for 30-60 min at 
30~  the reaction being stopped by the addition of 100 I11 0.5  N  NaOH. 
The color generated was read at 405 nm on a Multiskan (Titertek, Elfab Oy, 
England) and compared against a  standard curve obtained with standard 
alkaline phosphatase (Sigma Chemical Co.). 
Results 
In these studies, cell populations prepared from several sepa- 
rate calvarial isolates were used. The results presented below 
were obtained from one particular preparation of cells and 
were typical of the results obtained. The various bone-cell 
populations  isolated  showed  different  morphologies,  the 
early released populations being enriched with fibroblastic 
cells and the later released cells being enriched in osteoblas- 
tic cells (23). After a 24-h exposure to TGF-I~, slight mor- 
phological changes were apparent in the osteoblast-enriched 
populations that were more clearly observed after 4 d (Fig. 
1). Initially the osteoblastic cells were predominantly polyg- 
onal in shape but in the presence of TGF-13 changed to a vari- 
ety of morphologies that ranged from polygonal to spindle 
shaped. In contrast, the fibroblastic populations retained a 
predominantly spindle-shaped morphology in the presence 
of TGF-I3. 
Over the same time period little difference was observed 
in cell numbers compared with controls, except in popula- 
tion III where a slight increase in cell number was apparent 
in the presence of 1.0 ng/rrd TGF-I5 (Table I). TGF-I3 alone, 
or  in  combination  with  2.5  ng/ml  epidermal growth  fac- 
tor, did not stimulate colony formation when mixed popu- 
lations of the bone cells were grown on soft agar,  whereas 
NRK-49F indicator cells showed good anchorage-indepen- 
dent growth in the combined presence of TGF-I3 and epider- 
mal growth factor (results not shown). 
Protein synthesis, measured by incorporation of [35S]me- 
thionine, in cell-layer proteins of  control cultures was similar 
for each of the four bone cell populations, ranging from 5 
Figure 1. Phase-contrast micrographs of bone cell population IV. 
Cells from population IV were plated at 20,000  cells/dish  and 
grown to confluence before incubation with TGF-I~. Control cul- 
tures of population IV cells were enriched in polygonal cells, typi- 
cal of osteoblastic cells in culture (a), and retained their original 
morphology after 96 h whereas cells incubated in the presence of 
1.0 ng/ml TGF-~ exhibited a variety of morphologies (b and c). 
to 6 dpm/cell (Fig. 2 a). TGF-[~ at 0.1 ng/ml stimulated pro- 
tein synthesis 1.3-1.6-fold,  and at 1.0 ng/ml by 2.3-2.9-fold. 
Similar responses were observed for each population and, on 
examination of the radiolabeled proteins separated by SDS- 
PAGE on 5-20% gradient gels (Fig. 3 A), essentially identi- 
cal patterns were apparent for all control populations and 
their TGF-13-stimulated counterparts. In contrast, consider- 
able  differences  were  seen  in  the  radiolabeled  proteins 
secreted by these cells. As shown in Fig.  2 b,  synthesis of 
secreted proteins was least in population I (0.5 dpm/cell) be- 
ing almost one-half the level in populations II-IV. Significant 
stimulation of secreted protein synthesis was evident at both 
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Bone cell population 
Treatment  I  II  III  IV 
(cell number ￿  10 ~)  (cell number x  106)  (cell number ￿  10  ~)  (cell number x  106) 
Control  0.62  +  0.08  0.62  +  0.06  0.59  +  0.08  0.50  5:0.08 
TGF-I~ (1.0 ng/ml)  0.65  5:0.01  0.63  5:0.14  0.69  5: 0.0"  0.48  5:0.01 
* Significantly  different  from  control (P < 0.01). 
levels of  TGF-13, ranging from 1.6-2.5-fold at 0.1 ng/ml TGF- 
13 to 2.2-3.5-fold at  1.0 ng/ml with maximal stimulation of 
protein synthesis (2.75 dpm/cell) observed in population II. 
Analysis of the secreted proteins by SDS-PAGE on 5-20% 
gradient (not shown) and 7.5%  linear (Fig.  3 B) gels,  re- 
vealed similar profiles for all the populations with prominent 
radioactive bands in regions of fibronectin (220 kD), procol- 
lagens  (110-160 kD),  and  SPARC/osteonectin (40 kD).  In 
TGF-l~-treated cultures, quantitative differences in various 
protein bands were apparent.  The most prominent change 
was the appearance of a 48-kD protein which could be quan- 
titatively immunoprecipitated with an antiserum specific for 
the endothelial type plasminogen activator inhibitor (results 
not shown). From densitometric scans, this protein was in- 
creased at least 3-12-fold, with greater stimulation observed 
at the higher concentration of TGF-I~ in populations I and IV 
(Fig. 2  c). 
To analyze more specifically the effect of TGF-13 on the 
synthesis of secreted proteins, individual proteins were sepa- 
rated and quantitated. The amount of collagen synthesized 
was determined by selective digestion of collagenous pro- 
teins with highly purified bacterial collagenase. Because the 
collagen in the cell laver represented only a small proportion 
of the  total  radiolabeled  protein  (<5%)  the  results  were 
quite variable. Consequently, only the data for the collagen 
in the culture media are reported. In control cultures, the 
proportion of radioactivity in collagen relative to the total ra- 
diolabeled protein secreted varied from 20%  in population 
I to 24% in populations III and IV (Table II). Upon stimula- 
tion with TGF-13,  the proportion of radiolabeled collagen in- 
creased slightly, but significantly, in populations I and II with 
a maximal value of 27.6% observed in population II. Since 
the proportion of collagen was comparable between popula- 
tions, the relative amounts of radiolabeled collagen synthe- 
Figure 2.  Quantitation of [35S]- 
methionine-labeled proteins. The 
stimulation of protein  synthesis 
after a 24-h incubation with 0.1 
(lightly  stippled  bars)  and  1.0 
ng/ml  (heavily  stippled  bars) 
TGF-13  was  determined  from 
pulse-chase  experiments  using 
[35S]methionine  and  compared 
with  controls  (open  bars)  for 
each of the bone cell populations. 
(a) Cell-associated proteins;  (b) 
secreted proteins; (c) 48-kD pro- 
tein measured by densitometry; 
(d) collagen measured by selec- 
tive digestion with bacterial col- 
lagenase.  Differences  with  re- 
spect to controls were analyzed 
for  significance using  Students 
t-test. All increases were signif- 
icant (P > 0.01-0.001) with 1.0 
ng/ml and also for 0.1 ng/ml TGF-I] 
except for RC IV population in b, 
RC II, RC IlI, and RC IV popula- 
tions in c, and RC IV population 
in d. 
The Journal of Cell Biology.  Volume 106. 1988  918 Figure 3.  Analysis of [35S]methionine-labeled proteins by SDS-PAGE and fluorography. Aliquots containing approximately equal 
amounts of radioactivity from the cell layer (A) and chase medium (B) from each of the four bone cell populations (I-IV) maintained 
for 24 h in the absence or presence of TGF-B were analyzed by SDS-PAGE on 5-20% gradient (cell layer proteins) and 7.5% linear 
(medium proteins) gels under reducing conditions. (A) Lanes 1, 4, 7, and 10, controls; lanes 2, 5, 8, and 11, 0.1 ng/ml TGF-13; lanes 
3, 6, 9, and 12, 1.0 ng/ml TGF-IL Note the similar profiles for the radiolabeled proteins in the cell layer samples with increased band 
intensities in the position of fibronectin in the TGF-B-stimulated cells. (B) Lane 1, control; lane 2, 0.1 ng/ml TGF-B; lane 3, 1.0 ng/ml 
TGF-IB. 
sized (shown in Fig. 2 d) parallel the results obtained for 
secreted proteins shown in Fig. 2 b. Thus, stimulation of col- 
lagen synthesis ranged from 1.74-fold in population IV, with 
0.1 ng/ml TGF-13, to four-fold in population I, at 1.0 ng/ml 
~F-B. 
To determine whether or not TGF-I] has a selective effect 
on the type of collagen synthesized, media samples from 
populations I and IV were digested with pepsin and the ~t 
chains of collagen types I, III, and V were separated by SDS- 
PAGE (Fig. 4) and quantitated by densitometric analysis of 
fluorographs. Type I collagen was the major collagen with 
type III and V  collagens comprising  16.8  +  2.5%  (X  + 
SEM) and •1%,  respectively, in population I and  10.8 -I- 
0.5%  and 2.3  +  0.6%,  respectively, in population IV. As 
shown in Fig. 4,  several high and low relative molecular 
mass pepsin-resistant proteins that have not been character- 
ized also appear to be differentially affected by TGF-I~. In the 
presence of 1.0 ng/ml TGF-13, the proportion of  type UI colla- 
gen synthesized was decreased by 50%  to 8.1  +  0.3%  in 
population I and by 35%  to 7.0  +  0.5% in population IV. 
Fibronectin secreted into the culture medium was isolated 
by affinity chromatography on gelatin-Sepharose and then 
analyzed by SDS-PAGE and fluorography. A major protein 
band migrating in the position expected for fibronectin was 
observed with a  minor band at 70  kD,  demonstrating the 
effectiveness  of  the affinity  chromatography (Fig. 5). Quanti- 
tation of the radioactivity eluted from the affinity column by 
direct counting and by densitometric analysis of the protein 
on fluorographs revealed that similar amounts of radiola- 
beled fibronectin were secreted by each population and this 
represented ~05 % of the secreted proteins (Fig. 6 a). How- 
ever, because the amount of total secreted proteins is much 
less in population I (see Fig. 2), fibronectin is proportion- 
ately higher in this population. TGF-B at 0.1 ng/ml only in- 
Table II. Percentage of [35S]Methionine Incorporated  into Collagens 
Bone cell population 
Treatment  I  II  III  IV 
Control  20.4  +  0.8  22.9  +  0.8  24.0  +  1.1  24.2  +  0.3 
TGF-I~  (0.1  ng/ml)  23.8  +  0.3*  26.9  +  0.5*  27.1  +  0.2'  24.4  +  0.4 
TGF-I~  (1.0  ng/ml)  25.0  +  0.7*  27.6  +  0.1'  25.1  +  1.4  22.8  +  1.1 
* Significantly different from control  (P <  0.01). 
:~ Significantly different from control  (P <  0.005). 
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lagen  types  by  SDS-PAGE 
and fluorography. Aliquots of 
culture  medium  containing 
10,000 dpm radioactive  pro- 
tein were digested  with pep- 
sin at pH 2.2 for 4 h at 15~ 
The pepsin-resistant collagens 
were denatured  and the con- 
stituent ct chains separated by 
SDS-PAGE  on  7.5%  cross- 
linked gels using delayed re- 
duction. The relative amounts 
of each  ct  chain  was  deter- 
mined by densitometric scans 
of the fluorographs.  Samples 
of  control  (C)  and  TGF-13 
(1.0  ng/ml)-treated (T)  me- 
dium from cell populations I 
and IV are shown. 
creased fibronectin significantly in population IV, but at 1.0 
ng/ml fibronectin was increased in populations I, III, and IV, 
with a 3.5-fold increase in population IV. Since large amounts 
of fibronectin are also found associated with cell surfaces, 
the radiolabeled fibronectin in the cell layers was also quanti- 
tated.  TGF-13 increased  the  amount of radiolabeled  fibro- 
nectin in the cell layers of each population; in the presence 
of 1.0 ng/ml TGF-13 the degree of stimulation varied from 
threefold for population IV to eightfold  for population III 
(Fig.  6  b). 
When  specific immunoprecipitates,  prepared with anti- 
osteonectin antibody, were analyzed by SDS-PAGE the ma- 
jor protein  migrated as  a  distinct  doublet  with  a  relative 
molecular mass of 40 kD (Fig. 7). Small amounts of radio- 
labeled protein in the procollagen region were the only con- 
taminants. These proteins were not enriched and were selec- 
tively  removed  during  repeated  washings,  indicating  that 
they were not specifically associated with the antibody.  A 
similar pattern for the specific immunoprecipitate, including 
the presence of a doublet for osteonectin, was seen in earlier 
studies of porcine bone cells (20).  Under the culture condi- 
tions used,  SPARC/osteonectin isolated by immunoprecipi- 
tation  was  synthesized  in  appreciable amounts by all  cell 
populations and represented ~2 % of the radiolabeled pro- 
teins secreted. In the presence of TGF-13 at both concentra- 
tions,  the  synthesis  of  SPARC/osteonectin  was  markedly 
stimulated in populations I and II, with little or no stimula- 
tion  in  populations  III and IV (Fig.  8).  In most instances 
maximal or near maximal stimulation was observed with the 
lower level of TGF-13. 
Since  alkaline  phosphatase  activity  is  characteristically 
high  in  osteoblastic cells,  the basal  levels of this enzyme 
were measured together with changes effected by TGF-13 in 
population I and IV cells. As expected, the basal enzyme lev- 
els were higher in the osteoblast-enriched populations (2.4 
+  0.2 Ixmoles substrate hydrolyzed per hour per  106 cells) 
compared with the fibroblastic cells (1.2  +  0.1  lamoles/h/106 
cells). In the presence of TGF-13, a reduction in activity was 
Figure 5. Isolation of fibronectin. Radiola- 
beled  fibronectin  from equal  aliquots  of 
culture medium was quantitatively absorbed 
to gelatin-Sepharose. The radiolabeled pro- 
teins  in various  fractions  of the  isolation 
were  analyzed  by  SDS-PAGE  on  7.5% 
gels. Control cultures (C) and cells treated 
with 0.1  (Tf) and  1.0 ng/ml TGF-13 (T2) 
from populations  I and IV are shown,  o, 
original  sample  of radiolabeled  medium 
proteins; u, unbound radiolabeled proteins; 
b, specifically bound radiolabeled proteins. 
Some 70-kD, gelatin-binding protein (7OK) 
was also specifically bound in the fibronec- 
tin (Fn) preparation. 
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beled culture medium was incubated with gelatin-Sepharose as 
shown in Fig. 5 and the bound fibmnectin (Fn) quantitated by 
scintillation counting (a).  Since the fibronectin in the cell layer 
was not sufficiently purified by gelatin-affinity chromatography, 
quantitation was achieved by densitometric analysis from fluoro- 
graphs (b). (Open bars) Controls; (lightly stippled bars) 0.1 ng/ml 
TGF-13; (heavily stippled bars) 1.0 ng/ml TGF-13. Increases were 
significant according to Students t-test for 1.0 ng/ml TGF-13 in all 
(P > 0.01-0.001)  except RC II (a) and for 0.1 ng/ml TGF-13, ex- 
cept RC I and RC III (a), and RC IV (b). 
observed in both populations (0.6 +  0.1 lamoles/h/106 cells, 
a  50%  reduction in population I;  1.0  4-  0.1  tmaoles/h/106 
cells, a 58%  reduction in population IV). 
Discussion 
Because bone cells are  highly heterogenous  (2),  discrete 
populations of cells enriched in fibroblastic or osteoblastic 
cells were prepared to study the effects of TGF-13. Population 
IV  cells  were  polygonal in  morphology,  showed  a  good 
cAMP response to parathormone (23),  had relatively high 
alkaline phosphatase activity, and synthesized type I collagen 
almost exclusively; these are features that are characteristic 
of osteoblastic cells.  In contrast, population I  cells were 
mostly spindle shaped, synthesized higher amounts of type 
III collagen, and expressed lower levels of alkaline phospha- 
tase. Despite these distinct phenotypic differences, the radio- 
labeled proteins synthesized by these different populations 
were qualitatively similar (Fig. 2). 
Since TGF-I~ at 0.1 and 1.0 ng/ml gives half maximal and 
maximal responses, respectively, in anchorage-independent 
growth assays (24)  and in stimulating protein synthesis by 
human gingival fibroblasts in vitro (39), these concentrations 
were chosen to study effects on the calvarial cell populations. 
Despite the stimulation of cellular protein synthesis (Fig. 2 
a), TGF-I~ did not demonstrate a mitogenic effect on popula- 
tions I, II, and IV. These results are consistent with previous 
studies of TGF-I~ effects on human gingival (39) and lung (7) 
fibroblasts, and on rat calvarial cells (4). However, the lack 
of response in the osteoblastic population differs from the 
observations of Centrella, McCarthy, and Canalis (4) who 
reported a mitogenic effect of TGF-13 on a fetal rat calvarial 
cell population comprising population III and IV cells. Nota- 
bly, the mitogenic effects were cell density dependent and 
were more pronounced at levels of TGF-13 that were higher 
than used in this study. Although we observed a slight mito- 
genic effect on population III cells, this was not evident in 
the most osteoblastic population (IV) which, after prolonged 
incubation, often showed reduced cell numbers (results not 
shown). It is possible that TGF-13 has a mitogenic effect at 
higher concentrations, or it may exert a mitogenic effect on 
a subpopulation of bone cells that elute earlier than most of 
the osteoblastic cells. 
The TGF-13-induced stimulation of collagen and fibronec- 
tin synthesis, which may influence the change in the osteo- 
blast morphology (Fig. 1), has been suggested to be responsi- 
ble for the induction of anchorage-independent growth (9). 
However,  TGF-I~ alone, or in combination with epidermal 
growth factor, was unable to cause anchorage-independent 
growth of the calvarial cells, as observed previously with 
other freshly isolated normal cells in which matrix protein 
synthesis is stimulated by TGF-13 (39).  Thus, the induction 
of anchorage-independent growth that has been used to char- 
acterize TGF-~ appears to be a phenomenon exhibited typi- 
cally by established, nontumorigenic cells, and is unlikely, 
therefore, to have physiological significance. 
The two- to threefold stimulation of protein synthesis ob- 
served in cell layers in the presence of 1.0 ng/ml TGF-13 (Fig. 
2 a) was similar in all the populations and is also consistent 
with results obtained previously with human gingival fibro- 
blasts (39).  The majority of these proteins are cellular pro- 
teins that appear to be stimulated collectively by the action 
of TGF-13. TGF-13 also stimulated the synthesis of the total 
secreted proteins to a similar degree, as observed previously 
for fibroblasts (7,  39).  However,  the stimulation was more 
selective with the greatest increase observed in plasminogen 
activator inhibitor synthesis by cell populations I  and IV 
(Fig. 3).  Notably, plasminogen activator inhibitor has also 
been shown to be stimulated preferentially by TGF-13 in sev- 
eral epithelial (34) and human lung fibroblast lines (11, 13). 
Since the majority of collagen synthesized by cells in cul- 
ture is secreted into the culture medium within 2 h (10, 36), 
radiolabeled collagen was measured in 4-h chase medium af- 
ter a 30-min pulse with PS]methionine. In each population 
collagen synthesis was stimulated by TGF-13; in most cases 
the stimulation was slightly greater than that observed for the 
total secreted proteins, resulting in a higher percentage of 
radiolabel being incorporated into collagenous proteins (Ta- 
ble II). A preferential stimulation of collagen has been ob- 
served  in embryonic lung fibroblasts (7)  but not in adult 
gingival fibroblasts (39),  indicating possible age related dif- 
ferences in the response of fibroblasts to TGF-13. The stimu- 
lation of collagen synthesis by  TGF-13 in the  absence  of 
significant cell division supports the concept that cell growth 
and matrix synthesis are unrelated (4, 7, 39). In fetal bone 
cells TGF-I~ appears to act preferentially on type I collagen 
synthesis since little, if any, stimulation of type III collagen 
synthesis occurred in population I cells. Similarly, in popula- 
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nectin.  Rabbit  anti-porcine osteonectin  anti- 
body coupled to protein A-Sepharose was used 
to immunoprecipitate SPARC/osteonectin from 
equal aliquots of culture media. Samples from 
control (C) and 1.0 ng/ml TGF-13-treated (T) 
culture medium for rat calvarial populations I 
(RC I) and IV (RC IV) are shown, o, original 
medium sample;  u, unbound material;  n,  ra- 
diolabeled  protein  bound  nonspecifically  to 
protein  A-Sepharose;  s,  radiolabeled  protein 
bound specifically to osteonectin antibody. 
tion IV cells, type III collagen was stimulated less than two- 
fold compared with a threefold stimulation of total collagen. 
As there was no significant cell growth in the presence of 
TGF-[I, these results are not due to preferential proliferation 
of cells that constitutively produce lower amounts of type III 
collagen, but indicate a differential effect on collagen gene 
Figure 8. Stimulation of SPARC/osteonectin synthesis. SPARC/os- 
teonectin specifically immunoprecipitated  and analyzed by SDS- 
PAGE as shown in Fig. 7 was quantitated by densitometric  scan- 
ning of fluorographs. (Open bars) Controls; (lightly stippled bars) 
0.1  ng/ml; (heavily stippled  bars) 1.0 ng/ml TGF-[~; Increases at 
both levels of TGF-13 for populations RC I and II were significant 
(P > 0.001) whereas the differences in RC III and RC IV were not 
significant. 
expression.  This  contrasts  the  observations  of Fine  and 
Goldstein (7) who found no selectivity in the action of TGF-13 
on type I  and III collagen synthesis by human  lung fibro- 
blasts. 
TGF-13 also  stimulated  the  synthesis  and  secretion  of 
fibronectin in each of the populations.  Radiolabeled fibro- 
nectin  was much  greater in  the  medium of osteoblast-en- 
riched  population  whereas  the  greatest  increase  in  cell- 
associated fibronectin was observed in population I. These 
differences in stimulation of secreted versus cell-associated 
fibronectin may simply reflect a differential distribution of 
the protein. However, since fibronectin is known to be syn- 
thesized in various forms as a  result of differential mRNA 
splicing (19), it is possible that the various forms of fibronec- 
tin may distribute differently and may be regulated indepen- 
dently. 
The effects of'lGF-13 on SPARC/osteonectin synthesis ap- 
peared  to  be  more  selective  for  the  different  cell  types. 
Whereas TGF-[I stimulated SPARC/osteonectin synthesis in 
the fibroblast-enriched populations, which synthesize lower 
basal  levels  of  this  protein,  TGF-13 had  little  effect  on 
SPARC/osteonectin  synthesis  by  the  osteoblast-enriched 
population IV cells.  Since the osteoblast-enriched popula- 
tions would include some fibroblastic cells, in which SPARC/ 
osteonectin is stimulated, the net effect may reflect an inhibi- 
tion  of SPARC/osteonectin  synthesis by osteoblasts.  How- 
ever, as the function of SPARC/osteonectin is unknown, the 
significance of this result is unclear.  Nevertheless, SPARC/ 
osteonectin is a  major protein secreted by fibroblastic (37) 
The Journal of Cell Biology, Volume 106,  1988  922 and osteoblastic (20) cells as well as endodermal (15, 16), en- 
dothelial (26,  27),  and epithelial (14) cells, and a potential 
role for this calcium-binding protein has been indicated in 
both cellular differentiation (16) and in wound healing (27). 
This study  has shown some differences in the expression 
of  matrix  proteins  by  osteoblast-  and  fibroblast-enriched 
bone cell populations and a differential  modulation of these 
proteins by TGF-I~. The strong stimulation of protein synthe- 
sis by TGF-13 in all populations indicates a general increase 
in cell activity and connective tissue formation that could be 
important both in bone remodeling and fracture healing. The 
quantitative  differences in the stimulation of matrix proteins 
is likely to alter the nature of the matrix formed and conse- 
quently influence cell shape and behavior.  The decrease in 
alkaline phosphatase activity in osteoblastic cells caused by 
TGF-13 is consistent with TGF-13 effects on a mouse osteo- 
blastic cell line MC 3T3-E1 (18) and suggests a suppression 
of the osteoblast phenotype, as indicated also by the morpho- 
logical changes.  However, the decrease in type III collagen 
synthesis and the stimulation of bone phosphoprotein (Kubo- 
ta, T., J. L. Wrana, C. Domenicucci, W. T. Butler, and J. So- 
dek, unpublished data) by TGF-I~ indicate that not all osteo- 
blastic characteristics  are suppressed. 
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